| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |